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INTRODUCTION 
Across the world, Hypertension is one of the most 
common risk factors for cardiovascular disease (CVD) 
[1] hypertension is more in developing countries, due to 
rapid urbanization, unhealthy diet, and lifestyle changes 
that have lead to an increased rate of CVD in Southeast 
Asia, including India  [2]. According to the World 
Health Organization (WHO) report, India, by 2020, 
CVDs will be the leading cause of disability and death. 
Around 2.6 million people in India are expected to die 
due to coronary heart diseases by 2020 [3]. 
The association between hypertension and dyslipidemia 
is well established, and both may add up to increase 
patient's susceptibility to the development of Coronary 
Heart Disease (CHD). Hypertension is prone to cause 
Coronary Vascular Disease (CVD) in person with 
added risk factors such as elevated serum cholesterol. 
People with high blood pressure have more chances to 
have lipid abnormality than those with normal blood 
pressure [4]. 
Increased levels of triglyceride, cholesterol, and LDL-C 
are documented as risk factors for atherogenesis [5]. 
LDL-C in its oxidized or acetylated form has been 
identified as a significant atherogenic particle, as it not 
only loads macrophages with cholesterol for the 
formation of foam cells but also because it is 
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chemotactic for circulating monocytes, it is cytotoxic 
and can adversely alter coagulation pathways [6]. The 
blood level of HDL-C, in contrast, bears an inverse 
relationship of the risk of atherosclerosis and coronary 
heart disease that is higher the level, smaller the risk 
[7]. The objective of the study was to compare the lipid 
profile in Hypertensive patients and non-hypertensive 
individuals. 
MATERIAL AND METHODOLOGY    
Study design: Case-control analytical study 
Ethics: This study was initiated after obtaining consent 
from the patients and healthy volunteers and prior 
approval by the Institutional Ethical Committee.
Study duration: November 2018 to January 2019. 
Study place: Koppal Institute of Medical Sciences & 
Hospital, Karnataka 
Sample size: A total number of 60 human subjects of 
age ranging from 30-60 years were included in this 
study. 
Inclusion criteria: Participants were randomly 
selected from the OP of General Medicine.  Patients 
with systolic blood pressure above 140 mmHg or 
diastolic blood pressure above 90 mmHg were 
considered hypertensive patients. 
Exclusion criteria: Patients with diabetes mellitus, 
pregnant woman, Renal disorders, Rheumatoid 
arthritis, active hepatic disease, on oral contraceptives, 
on thiazide and/or beta-blockers, and any patients on 
lipid-lowering drugs. 
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Grouping: Out of the 60 subjects, 30 newly diagnosed 
hypertensive patients(cases) and the equal number of 
age and sex-matched without hypertension were 
selected as controls. 
    
Five milliliters (5ml) venous 
blood was obtained between 08:00 and 09.00 a.m. 
after a 12-hour fasting period. The blood was allowed 
to clot for one hour. Centrifugation was done to 
separate the serum for 10 minutes, after which serum 
was isolated into a dry plain plastic screw-capped 
container and refrigerated (at -20˚C) before analyses. 
The analysis was done on fully auto analyzer XL 640 
in Biochemistry Lab.  
Serum total cholesterol levels was determined by 
enzymatic (CHOD-PAP) colorimetric method [8] and 
triglyceride by enzymatic (GPO-PAP) method [9] 
HDL-cholesterol and LDL-cholesterol were estimated 
using precipitant [10] and Friedewald formula [11,12]. 
Above all, parameters under investigation were 
determined in the serum of patients and controls using 
commercially available reagent kits. 
 
Statistical analysis: By student’s “ t ” test statistical 
significance was evaluated between control and study 
groups. 
 
RESULTS  
Table 1: Age Distribution for Cases and Controls 
 
Age in Years 
Controls Cases 
N (%) (%) 
31 – 40   
41 - 50 10  10  
51 - 60 15  15  
Male 20  20  
Female 10  10  
Table 2: BP and Lipid profile distribution of Controls 
and cases 
Significantly higher levels of serum Triglycerides, serum 
Cholesterol, serum LDL-Cholesterol and statistically 
insignificant difference of HDL-Cholesterol were found 
among Hypertensive patients compared to non-
hypertensive individuals. 
Table 3: BP and Lipid profile distribution according to 
sex in Controls and cases 
DISCUSSION  
In this present study, serum lipid profiles of hypertensive 
patients and healthy volunteers were estimated. 
Significantly higher levels of serum cholesterol, 
triglyceride and LDL-cholesterol were found in 
hypertensive patients than those of the control group, and 
no statistically significant difference of HDL-Cholesterol 
was found in hypertensive patients than those of the 
control group. Regular evaluation of lipid profile is a 
must in all hypertensive cases to stop further aggravation 
and risk of CVDs. 
Category Controls Cases P-value 
Systolic B.P  
(mm/Hg) 
120.4±11.65 156.13±8.43 <1.04 
Diastolic B.P  
(mm/Hg) 
76.2±4.11 98.2±5.85 <1.06 
TG (mg/dl) 125.83± 12.34 139.8 ± 18.72 <0.001 
TC (mg/dl) 178.76 ± 37.21 202.93±28.44 <0.006 
LDL-C (mg/dl) 127.83 ± 14.65 141.63±11.59 <0.0001 
TG (mg/dl) 41 ± 2.81 32.26 ± 3.66 <2.02 
Category Controls Cases P value 
Men 
Systolic B.P  
(mm/Hg) 
117.5±10.6
7 
155.2±7.87 <1.14 
Diastolic B.P  
(mm/Hg) 
76.4±3.64 97.9±5.21 <1.18 
TG (mg/dl) 
126.8±10.5
8 
138±20.52 
<0.03
8 
TC (mg /dl) 
177.1±36.7
5 
198.5±27.2
1 
<0.00
4 
LDL-C (mg/dl) 
130.5±15.6
3 
143.3±11.9
2 
<0.00
5 
HDL-C (mg/
dl) 
40.55±2.94 32.55±4.13 <3.91 
Female 
Systolic B.P  
(mm/Hg) 
126.2± 158± <4.64 
Diastolic B.P  
(mm/Hg) 
75.8± 98.8± <4.06 
TG (mg/dl) 124± 143.5± <0.01 
TC (mg/dl) 182.1± 211.8± 
<0.07
7 
LDL-C (mg/dl) 122.5± 138.2± <0.05 
HDL-C (mg/
dl) 
41.9± 31.7± <3.72 
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These findings of Significantly higher levels of serum 
cholesterol, triglyceride, and LDL-cholesterol in 
hypertensive patients than those of the control group 
were entirely in agreement with the results of some 
previous studies. 
Sabri [13], and Yin [14], showed that total cholesterol 
level was higher in hypertensive patients than non-
hypertensive subjects. 
Shahadat et al., [15] Adedeji et al., [16] and Shah et al. 
[17] in their respective studies showed that total 
cholesterol and triglycerides were higher in 
hypertensive patients 
Oparil et al. explained different mechanisms through 
which 
First, arteriosclerosis in the larger arteries due to the
deposition of 
collagen leads to arterial stiffness. This may lead to 
increased SBP seen with increasing age. Besides
, lipidemias lead to 
endothelial dysfunction and im
 
with more TC and 
less HDL-C levels. And also, 
lated with TC levels [20]. 
Besides, dyslipidemia can also cause damage to the renal 
microvasculature with the 
dyslipidemia is linked to renal decline [21]. 
However, no statistical significance of HDL-Cholesterol 
was found among Hypertensive patients in comparison 
with the healthy volunteers. 
CONCLUSION  
Dyslipidemia is associated with hypertension. 
Hypertension and dyslipidemia can be modified either 
by proper lifestyle changes or medical management or 
by the combination of both. This study recommends 
that hypertensive patients need the measurement of 
blood pressure and lipid profile at regular intervals to 
prevent cardiovascular diseases. 
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